arrow
L

Laura Boekel

department of rheumatology
H指数:16
被引数:1,066

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment

在免疫抑制治疗下,经多次mRNA疫苗接种后SARS-CoV-2抗体谱的演变

2025-03-010
PRE
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination

T细胞活化标志物CD38和hla-dr指示SARS-CoV-2 mRNA疫苗接种后anti-CD20-treated多发性硬化症患者的非血清转化

2024-03-281
OAAI
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination

mRNA疫苗接种后,dupilumab和TNF抑制剂治疗的患者抑制了IgG4类别转换

2024-03-046
OAAI
Longitudinal rheumatoid factor autoantibody responses after SARS-CoV-2 vaccination or infection

SARS-CoV-2疫苗接种或感染后类风湿因子自身抗体的纵向反应

2024-02-290
OAAI
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands

炎症性风湿性疾病患者的COVID后状况: 荷兰的一项前瞻性队列研究

2023-07-019
OAAI
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

免疫介导的炎性疾病患者的原发性SARS-CoV-2感染: 长期体液免疫反应及其对疾病活动的影响

2023-05-175
OAAI
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations

SARS-CoV-2疫苗接种后免疫介导的炎症性疾病患者的疾病活动

2023-02-0114
OA
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period

在omicron占优势时期,免疫介导的炎症性疾病患者的SARS-CoV-2突破性感染

2022-11-0116
OAAI
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273
2022-07-1516
OA
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases Comment
2022-05-0116
OAAI
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases

免疫介导的炎性疾病患者SARS-CoV-2疫苗接种后短期不良事件的相关危险因素

2022-03-0219
OAAI
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
2021-11-01124
OAAI